Read

Stark / Raving Health Opens Office in Boston’s Seaport Innovation District

Historic innovation district welcomes clinical trial marketing leader as Stark / Raving Health moves headquarters to Boston's vibrant Fort Point Channel, embracing a neighborhood that mirrors their own evolution from tradition to transformation.

BOSTON – Stark / Raving Health, a leading provider of clinical trial marketing and patient recruitment solutions, today announced the relocation of its headquarters to 369 Congress Street in Boston's vibrant Fort Point Channel neighborhood, situated in the heart of the Seaport Innovation District.

The new office space positions the company at the epicenter of Boston's thriving innovation ecosystem, providing an inspiring environment that reflects the company's commitment to innovative approaches in clinical trial patient recruitment.

"Our move to Fort Point Channel represents an exciting new chapter for Stark / Raving Health," said Matthew Stumm, President and Founder. "This historic district, with its rich legacy of transformation and innovation, perfectly aligns with our mission of revolutionizing patient recruitment for clinical trials. The dynamic energy of this neighborhood will further fuel our creative and strategic capabilities as we continue to serve clients worldwide."

The Fort Point Channel area boasts a remarkable history dating back to the 1700s, evolving from a colonial fort to a manufacturing and warehousing hub, and now stands as New England's largest artist community and a thriving center for innovation. This unique blend of historical significance and forward-thinking culture creates an ideal setting for Stark / Raving Health's continued growth and development.

The new location offers expanded facilities to accommodate the company's growing team while enhancing collaboration opportunities with Boston's extensive network of healthcare, biotech, and technology organizations.

About Stark / Raving Health

Stark / Raving Health combines clinical trial expertise, award-winning creativity, and sophisticated media strategies to accelerate global patient recruitment. Operating in over 50 countries and 70 languages, we drive enrollment success through our unique blend of therapeutic insight and digital innovation. This powerful approach has established us as the trusted partner for leading biotechs, pharmaceutical companies, and CROs transforming clinical trials through strategic, patient-inspired campaigns.

To learn more, visit www.starkravinghealth.com